Literature DB >> 33504100

An Overview of the Synthesis and Antimicrobial, Antiprotozoal, and Antitumor Activity of Thiazole and Bisthiazole Derivatives.

Anca-Maria Borcea1,2, Ioana Ionuț1, Ovidiu Crișan3, Ovidiu Oniga1.   

Abstract

Thiazole, a five-membered heteroaromatic ring, is an important scaffold of a large number of synthetic compounds. Its diverse pharmacological activity is reflected in many clinically approved thiazole-containing molecules, with an extensive range of biological activities, such as antibacterial, antifungal, antiviral, antihelmintic, antitumor, and anti-inflammatory effects. Due to its significance in the field of medicinal chemistry, numerous biologically active thiazole and bisthiazole derivatives have been reported in the scientific literature. The current review provides an overview of different methods for the synthesis of thiazole and bisthiazole derivatives and describes various compounds bearing a thiazole and bisthiazole moiety possessing antibacterial, antifungal, antiprotozoal, and antitumor activity, encouraging further research on the discovery of thiazole-containing drugs.

Entities:  

Keywords:  biological activity; bisthiazole; derivatives; synthesis; thiazole

Mesh:

Substances:

Year:  2021        PMID: 33504100      PMCID: PMC7865802          DOI: 10.3390/molecules26030624

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  84 in total

Review 1.  Bacterial beta-ketoacyl-acyl carrier protein synthase III (FabH): an attractive target for the design of new broad-spectrum antimicrobial agents.

Authors:  Yunierkis Pérez Castillo; Miguel Angel Cabrera Pérez
Journal:  Mini Rev Med Chem       Date:  2008-01       Impact factor: 3.862

2.  In vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives.

Authors:  Parameshwar Makam; Prasoon Kumar Thakur; Tharanikkarasu Kannan
Journal:  Eur J Pharm Sci       Date:  2013-11-11       Impact factor: 4.384

Review 3.  Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery.

Authors:  Adile Ayati; Saeed Emami; Ali Asadipour; Abbas Shafiee; Alireza Foroumadi
Journal:  Eur J Med Chem       Date:  2015-04-13       Impact factor: 6.514

4.  Design, synthesis and biological evaluation of novel β-pinene-based thiazole derivatives as potential anticancer agents via mitochondrial-mediated apoptosis pathway.

Authors:  Yunyun Wang; Chenliang Wu; Qiangjian Zhang; Yu Shan; Wen Gu; Shifa Wang
Journal:  Bioorg Chem       Date:  2018-12-10       Impact factor: 5.275

5.  Synthesis and antiparasitic activity of new bis-arylimidamides: DB766 analogs modified in the terminal groups.

Authors:  Zong-ying Liu; Tanja Wenzler; Reto Brun; Xiaohua Zhu; David W Boykin
Journal:  Eur J Med Chem       Date:  2014-06-12       Impact factor: 6.514

6.  Triazole incorporated thiazoles as a new class of anticonvulsants: design, synthesis and in vivo screening.

Authors:  Nadeem Siddiqui; Waquar Ahsan
Journal:  Eur J Med Chem       Date:  2010-01-13       Impact factor: 6.514

7.  FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations.

Authors:  Lauretta Odogwu; Luckson Mathieu; Gideon Blumenthal; Erin Larkins; Kirsten B Goldberg; Norma Griffin; Karen Bijwaard; Eunice Y Lee; Reena Philip; Xiaoping Jiang; Lisa Rodriguez; Amy E McKee; Patricia Keegan; Richard Pazdur
Journal:  Oncologist       Date:  2018-02-07

8.  One-Pot Synthesis of Novel Thiazoles as Potential Anti-Cancer Agents.

Authors:  Abdelwahed R Sayed; Sobhi M Gomha; Eman A Taher; Zeinab A Muhammad; Hesham R El-Seedi; Hatem M Gaber; Mahgoub M Ahmed
Journal:  Drug Des Devel Ther       Date:  2020-04-03       Impact factor: 4.162

9.  Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (Mpro).

Authors:  Sraa Abu-Melha; Mastoura M Edrees; Sayed M Riyadh; Mohamad R Abdelaziz; Abdo A Elfiky; Sobhi M Gomha
Journal:  Molecules       Date:  2020-10-06       Impact factor: 4.411

Review 10.  Targeting tumour microenvironment by tyrosine kinase inhibitor.

Authors:  Hor-Yue Tan; Ning Wang; Wing Lam; Wei Guo; Yibin Feng; Yung-Chi Cheng
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

View more
  5 in total

1.  Synthesis and characterization of two new mixed-ligand Cu(II) complexes of a tridentate NN'O type Schiff base ligand and N-donor heterocyclic co-ligands: In vitro anticancer assay, DNA/human leukemia/COVID-19 molecular docking studies, and pharmacophore modeling.

Authors:  Liana Ghasemi; Mahdi Behzad; Ali Khaleghian; Alireza Abbasi; Anita Abedi
Journal:  Appl Organomet Chem       Date:  2022-02-24       Impact factor: 4.072

2.  Urea-thiazole/benzothiazole hybrids with a triazole linker: synthesis, antimicrobial potential, pharmacokinetic profile and in silico mechanistic studies.

Authors:  Nisha Poonia; Kashmiri Lal; Ashwani Kumar; Anil Kumar; Srikanta Sahu; Anurag T K Baidya; Rajnish Kumar
Journal:  Mol Divers       Date:  2021-10-20       Impact factor: 3.364

3.  Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study.

Authors:  Manar G Salem; Dina M Abu El-Maaty; Yassmina I Mohey El-Deen; Basem H Elesawy; Ahmad El Askary; Asmaa Saleh; Essa M Saied; Mohammed El Behery
Journal:  Molecules       Date:  2022-07-31       Impact factor: 4.927

4.  A Novel Minor Groove Binder as a Potential Therapeutic Agent for Myotonic Dystrophy Type 1.

Authors:  Ke Li; Sarah B Krueger; Steven C Zimmerman
Journal:  ChemMedChem       Date:  2021-06-10       Impact factor: 3.540

5.  Thiazole-Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation.

Authors:  Ashok Babu Kasetti; Indrajeet Singhvi; Ravindra Nagasuri; Richie R Bhandare; Afzal B Shaik
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.